January 22, 2021 – Premier Inc. (Charlotte, NC) through its ProvideGx program, has partnered with Pfizer Inc. to supply five essential medications to healthcare providers, helping to meet the immediate and long-term supply needs of medications necessary to a range of patient care interventions, including some that have been critical during the COVID-19 pandemic.
The five medicines include:
- Labetalol, a beta blocker that is used to treat high blood pressure.
- Diazepam, a controlled substance used as an anti-anxiety medication
- Lorazepam, a controlled substance used as an anti-anxiety medication
- fentanyl citrate, a controlled substance used to prevent pain for short periods of time, usually before anesthesia is administered or immediately after surgical procedures
- 0.9 percent sodium chloride injection, which is used to dilute other medications before injection
Pfizer has made significant investments in its injectables manufacturing network to support increased capacity and order fulfillment rates. The enhanced agreement with Premier helps facilitate increased access to these medicines for Premier member institutions and their patients.
The financial terms of Premier’s agreement with Pfizer were not disclosed.